Cardiac tumors: Difference between revisions
No edit summary |
|||
(12 intermediate revisions by 2 users not shown) | |||
Line 10: | Line 10: | ||
==[[Cardiac tumors overview|Overview]]== | ==[[Cardiac tumors overview|Overview]]== | ||
__NOTOC__ | |||
__NOTOC__ | |||
==[[Cardiac tumors historical perspective|Historical Perspective]]== | ==[[Cardiac tumors historical perspective|Historical Perspective]]== | ||
==[[Cardiac tumors classification|Classification]]== | ==[[Cardiac tumors classification|Classification]]== | ||
[[Cardiac tumors classification#Primary cardiac tumors|Primary cardiac tumors]] | [[Cardiac tumors classification#Secondary cardiac tumors|Secondary cardiac tumors]] | [[Cardiac tumors classification#Primary cardiac tumors|Primary cardiac tumors]] | [[Cardiac tumors classification#Secondary cardiac tumors|Secondary cardiac tumors]] | ||
Line 48: | Line 52: | ||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:Cardiovascular system]] | [[Category:Cardiovascular system]] | ||
Latest revision as of 11:04, 23 May 2022
For patient information click here
Cardiac tumors | |
Cardiac tumors Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Cardiac tumors On the Web |
American Roentgen Ray Society Images of Cardiac tumors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Varun Kumar, M.B.B.S. Syed Hassan A. Kazmi BSc, MD [3]
Overview
Historical Perspective
Classification
Primary cardiac tumors | Secondary cardiac tumors
Pathophysiology
Causes
Differentiating Cardiac Tumors from other Diseases
Epidemiology and Demographics
Risk Factors
Risk Factors for Embolization
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
Case #1 | Case #2: Cardiac lymphoma